Fresenius Kabi Receives FDA 510 (k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora ...
The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...
Learn about Fresenius Kabi India Pvt. Ltd in Pune, Maharashtra.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or ...
TORONTO, Jan. 8, 2025 /CNW/ - Fresenius Kabi Canada proudly announces the recent Health Canada Notice of Compliance (NOC) for Otulfi TM, an ustekinumab biosimilar indicated for Crohn's disease ...